Bharat Biotech’s Covaxin found to neutralise ‘617’ variant of Covid-19, says Dr Fauci
White House Chief Medical Adviser and USA’s top pandemic expert Dr Anthony Fauci said on Tuesday while speaking to the reporters that Bharat Biotech’s Covaxin has been found to neutralise ‘617’ variant of the deadly virus.
“This is something where we're still gaining data on a daily basis. But the most recent data was looking at convalescent Sera of COVID-19 cases and people who received the vaccine used in India, the Covaxin. It was found to neutralise the '617' variant,” he said. Fauci stated vaccination could be very, very important antidote against the coronavirus.